Zai Lab Ltd

Phase 1 AI-extracted

zoci

2L+ SCLC, 1L SCLC, and other neuroendocrine carcinomas (NECs)

Resolved

7days ago

Phase 1 readout · Jun 30, 2026

What's at stake Phase 1 trial results for zoci in 2L+ SCLC, 1L SCLC, and other neuroendocrine carcinomas (NECs) are due Jun 30, 2026. A clean hit validates the program; a miss can gap the stock down hard.

Primary source · SEC 8-K verified 16h ago

“– Extrapulmonary NECs: Data from the Phase 1b portion of the ongoing global Phase 1b/2 study.”

Add to calendar Post on X Reddit

Provenance